Why Insmed Incorporated (INSM) Stock Rose 20.9% on Nov 19, 2026
What happened
Insmed Incorporated (INSM) moved +20.89% from $119.50 to $144.46 on 2026-11-19 after Bloomberg reported that pharmaceutical giant Sanofi is exploring a potential acquisition of the company. Talks are ongoing with no guarantee of completion, but analysts estimate Insmed could command $170–$210 per share in a buyout, suggesting a 20–50% acquisition premium from the pre-announcement price.
Monitor for updates on Sanofi takeover negotiations and any competing bids; next scheduled earnings announcement is 2027-02-18.
Other developments that session
Insmed stock surges on report that Sanofi is considering acquiring the biopharma company.
Frequently asked questions
Why did Insmed Incorporated (INSM) stock rise on Nov 19, 2026?
Insmed Incorporated (INSM) moved +20.89% from $119.50 to $144.46 on 2026-11-19 after Bloomberg reported that pharmaceutical giant Sanofi is exploring a potential acquisition of the company. Talks are ongoing with no guarantee of completion, but analysts estimate Insmed could command $170–$210 per share in a buyout, suggesting a 20–50% acquisition premium from the pre-announcement price.
How much did INSM stock rise on Nov 19, 2026?
INSM rose 20.9% during the Nov 19, 2026 trading session.
